| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 15 |
| 1 | INFLIXIMAB | 9 |
| 2 | METHOTREXATE SODIUM | 9 |
| 3 | METHOTREXATE | 8 |
| 4 | MOXIFLOXACIN HYDROCHLORIDE | 8 |
| 5 | RITUXIMAB | 8 |
| 6 | MOXIFLOXACIN | 7 |
| 7 | TACROLIMUS | 6 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 9 | TACROLIMUS OINTMENT 0.1% | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOXIFLOXACIN HYDROCHLORIDE | 8 | 0.0004 |
| 1 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 2 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 1 | 0.0002 |
| 3 | LIOTHYRONINE SODIUM | 1 | 0.0001 |
| 4 | AZELASTINE | 2 | 0.0001 |
| 5 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | VALGANCICLOVIR | 2 | 0.0001 |
| 7 | DASPONE | 1 | 0.0001 |
| 8 | DAPSONE GEL, 5% | 1 | 0.0001 |
| 9 | ASFOTASE ALFA | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 1 | Sulfone [EPC] | 1 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Cholinergic Nicotinic Agonist [EPC] | 2 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 8 | 0.0000 |
| 7 | Catecholamine [EPC] | 2 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 9 | Anti-IgE [EPC] | 2 | 0.0000 |